Task order 1 -title: are reductions in BOE, boph, and other health risk markers proportional to reductions in cigarette smoking upon switching to ends
Ended Awarded Last action
- Contract number
- 75F40123F19001
- Awardee
-
Lovelace Biomedical Research Institute UEI MBT9RXJJ7428
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $3,872,713
Award facts
- Opportunity
-
- 75F40123R00028 Solicitation number
- Contract value 100% obligated
- $3,872,713.00 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541690 Other Scientific and Technical Consulting Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Calverton, MD 20705, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Terminate for Convenience | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $3,872,713 |
About this award
This is a firm fixed-price delivery order awarded by the Food and Drug Administration (FDA) to Lovelace Biomedical Research Institute, a not-for-profit preclinical contract research organization. The $3,872,713 task order, which is not set aside, is for a study to evaluate whether reductions in biomarkers of exposure, biomarkers of potential harm, and other health risk markers are proportional to reductions in cigarette smoking when switching to electronic nicotine delivery systems. Lovelace Biomedical Research Institute has experience conducting animal studies, analytical testing, and research for various federal agencies like the National Institutes of Health, Department of Defense, and Department of Health and Human Services. This task order is part of a larger indefinite delivery, indefinite quantity (IDIQ) contract vehicle for the FDA.
Quick answers
Who was awarded contract 75F40123F19001?
75F40123F19001 was awarded to Lovelace Biomedical Research Institute by Food and Drug Administration (Department of Health and Human Services) on September 27, 2023.
How much is contract 75F40123F19001 worth?
The government has obligated $3,872,713 on 75F40123F19001.
Is contract 75F40123F19001 an order under another contract?
Yes. 75F40123F19001 is a delivery order under 75F40123D00039, an indefinite delivery contract.
Was contract 75F40123F19001 competed?
The extent of competition for 75F40123F19001 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award